X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-16 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $5.31 | +50,000 | 11,847,224 | 0% | +$265,630 | ||||||
2024-08-14 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $6.00 | +85,000 | 11,797,224 | +1% | +$510,315 | ||||||
2024-06-11 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $5.88 | +45,000 | 11,712,224 | 0% | +$264,600 | ||||||
2024-05-17 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $5.56 | +100,000 | 11,667,224 | +1% | +$556,170 | ||||||
2024-05-14 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $5.12 | +150,000 | 11,567,224 | +1% | +$767,805 | ||||||
M | 2024-05-10 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $4.57 | +300,000 | 11,417,224 | +3% | +$1,370,370 | |||||
D | 2023-03-09 | TMCI | Treace John T. | Chief Exec Offer, 10% | S - Sale+OE | $24.41 | -2,075 | 10,945,984 | 0% | -$50,651 | |||||
2022-11-21 | TMCI | Treace John T. | Chief Exec Offer, 10% | P - Purchase | $21.83 | +15,000 | 10,865,584 | 0% | +$327,405 | ||||||
2022-11-17 | TMCI | Treace John T. | Chief Exec Offer, 10% | P - Purchase | $21.67 | +10,000 | 10,850,584 | 0% | +$216,714 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |